1. Home
  2. RLYB vs UCL Comparison

RLYB vs UCL Comparison

Compare RLYB & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLYB
  • UCL
  • Stock Information
  • Founded
  • RLYB 2018
  • UCL 2014
  • Country
  • RLYB United States
  • UCL Hong Kong
  • Employees
  • RLYB N/A
  • UCL N/A
  • Industry
  • RLYB Biotechnology: Pharmaceutical Preparations
  • UCL Telecommunications Equipment
  • Sector
  • RLYB Health Care
  • UCL Consumer Discretionary
  • Exchange
  • RLYB Nasdaq
  • UCL Nasdaq
  • Market Cap
  • RLYB 45.2M
  • UCL 48.7M
  • IPO Year
  • RLYB 2021
  • UCL 2020
  • Fundamental
  • Price
  • RLYB $0.95
  • UCL $2.13
  • Analyst Decision
  • RLYB Buy
  • UCL
  • Analyst Count
  • RLYB 6
  • UCL 0
  • Target Price
  • RLYB $8.10
  • UCL N/A
  • AVG Volume (30 Days)
  • RLYB 106.4K
  • UCL 378.9K
  • Earning Date
  • RLYB 11-07-2024
  • UCL 11-26-2024
  • Dividend Yield
  • RLYB N/A
  • UCL N/A
  • EPS Growth
  • RLYB N/A
  • UCL 169.91
  • EPS
  • RLYB N/A
  • UCL 0.11
  • Revenue
  • RLYB $598,000.00
  • UCL $87,405,000.00
  • Revenue This Year
  • RLYB N/A
  • UCL $11.23
  • Revenue Next Year
  • RLYB N/A
  • UCL $27.52
  • P/E Ratio
  • RLYB N/A
  • UCL $18.91
  • Revenue Growth
  • RLYB N/A
  • UCL 4.73
  • 52 Week Low
  • RLYB $0.93
  • UCL $0.97
  • 52 Week High
  • RLYB $3.46
  • UCL $3.30
  • Technical
  • Relative Strength Index (RSI)
  • RLYB 37.53
  • UCL 62.21
  • Support Level
  • RLYB $0.93
  • UCL $1.41
  • Resistance Level
  • RLYB $1.24
  • UCL $3.30
  • Average True Range (ATR)
  • RLYB 0.08
  • UCL 0.39
  • MACD
  • RLYB -0.02
  • UCL 0.11
  • Stochastic Oscillator
  • RLYB 6.45
  • UCL 45.33

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

About UCL uCloudlink Group Inc.

Ucloudlink Group Inc provides mobile data connectivity and portable WiFi services. The business operates under uCloudlink 1.0, which focuses on cross-border travelers that need mobile data connectivity services across different countries. Under uCloudlink 2.0, provides mobile data connectivity services to local users across different MNOs in a single country. It generates revenue from the provision of data connectivity services, and the sales of terminals and sales of data related products.

Share on Social Networks: